News
03-18-2015, 02:28 AM
A means of reprogramming a flawed immune response into an efficient anti-tumoral one was brought to light by the results of a translational trial relating to breast cancer.
More... (http://www.medicalnewstoday.com/releases/290981.php)
More... (http://www.medicalnewstoday.com/releases/290981.php)